| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vaishali Pharma Limited (NSE: VAISHALI)
VAISHALI Technical Analysis
3
| As on 30th Apr 2024 VAISHALI SHARE Price closed @ 158.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 145.07 & Buy for SHORT-TERM with Stoploss of 153.18 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VAISHALISHARE Price
| Open | 159.95 | Change | Price | % |
| High | 161.50 | 1 Day | -0.05 | -0.03 |
| Low | 157.00 | 1 Week | -3.50 | -2.16 |
| Close | 158.50 | 1 Month | 18.45 | 13.17 |
| Volume | 53506 | 1 Year | 7.65 | 5.07 |
| 52 Week High 183.55 | 52 Week Low 36.45 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.20 | -1.86% |
| YESBANK | 26.15 | -3.51% |
| NHPC | 96.20 | 3.00% |
| PNB | 141.05 | 2.77% |
| IDFCFIRSTB | 82.15 | 0.61% |
| RECLTD | 507.15 | 9.54% |
| IOC | 168.85 | -4.47% |
| MAHABANK | 70.10 | -1.34% |
| HFCL | 100.50 | 2.60% |
| TATASTEEL | 165.00 | -1.43% |
NSE INDIA Top Gainers Stocks
| HISARMETAL | 222.00 | 20.00% |
| WILLAMAGOR | 40.95 | 19.91% |
| NGIL | 61.65 | 15.67% |
| LIKHITHA | 351.20 | 12.80% |
| COMPUSOFT | 36.45 | 11.98% |
| PDMJEPAPER | 83.50 | 11.71% |
| BFUTILITIE | 862.25 | 10.74% |
| POWERINDIA | 9578.75 | 10.53% |
| IRIS | 155.15 | 10.00% |
| HINDMOTORS | 34.65 | 10.00% |
NSE INDIA Top Losers Stocks
| VAISHALI Daily Charts |
VAISHALI Intraday Charts |
Whats New @ Bazaartrend |
VAISHALI Free Analysis |
|
|
VAISHALI Important Levels Intraday
| RESISTANCE | 167.17 |
| RESISTANCE | 164.39 |
| RESISTANCE | 162.67 |
| RESISTANCE | 160.95 |
| SUPPORT | 156.05 |
| SUPPORT | 154.33 |
| SUPPORT | 152.61 |
| SUPPORT | 149.83 |
VAISHALI Target May 2024
| 4th UP Target | 262.82 |
| 3rd UP Target | 225.77 |
| 2nd UP Target | 202.87 |
| 1st UP Target | 179.97 |
| 1st DOWN Target | 114.63 |
| 2nd DOWN Target | 91.73 |
| 3rd DOWN Target | 68.83 |
| 4th DOWN Target | 31.78 |
VAISHALI Weekly Target
| 4th UP Target | 178.23 |
| 3rd UP Target | 171.68 |
| 2nd UP Target | 167.63 |
| 1st UP Target | 163.58 |
| 1st DOWN Target | 152.02 |
| 2nd DOWN Target | 147.97 |
| 3rd DOWN Target | 143.92 |
| 4th DOWN Target | 137.37 |
VAISHALI Target2024
| 4th UP Target | 388.04 |
| 3rd UP Target | 321.95 |
| 2nd UP Target | 281.09 |
| 1st UP Target | 240.24 |
| 1st DOWN Target | 123.66 |
| 2nd DOWN Target | 82.81 |
| 3rd DOWN Target | 41.95 |
| 4th DOWN Target | -24.14 |
Vaishali Pharma Limited ( NSE INDIA Symbol : VAISHALI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VAISHALI Synopsis Technicals View
| 50 Day EMA |
N/A (Short Term) |
N/A | |
| 100 Day EMA | N/A (Mid Term) | N/A | |
| 200 Day EMA | N/A (Long Term) | N/A | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 39.23 | Sideways | |
| MFI (14) | MFI is 27.77 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -79.76 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 53.04 | |
| 10 Day Avg Volume | Traded -2.64 % Less then 10 Day Average Volume | ||
VAISHALI Other Details
| Segment | EQ | |
| Market Capital | 364371200.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
VAISHALI Address
 |
||
VAISHALI Latest News
VAISHALI Business Profile
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India. Address: 706 to 709, Aravalli Business Center, Mumbai, India, 400092
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service